Navigation Links
Aderans Research BIO International Press Release
Date:5/31/2009

ARI a Key Presence at Recent BIO International Convention

Atlanta, GA (PRWEB) May 31, 2009 -- Aderans Research Institute Inc. (ARI) was a notable presence at the recent BIO International Convention. The leading hair regeneration company joined more than 1,800 companies from 58 countries around the globe at the world's largest annual event for the biotechnology industry, held May 18-21 at the Georgia World Congress Center.

Co-located in Atlanta and Philadelphia, ARI is actively engaged in the study of state-of-the-art cell-based hair regeneration for men and women. The company recently launched Phase 2 of its clinical study to assess the impact of its regenerative cell treatment on pattern hair loss, also known as androgenetic alopecia. Phase 2 of the study is being conducted in six U.S. cities: Atlanta, Boston, New York, Raleigh, Houston, and Washington DC. Phase 1 was conducted exclusively in the United Kingdom.

"Our research is focused on generating a tissue engineering solution to the regeneration of hair," said Kurt Stenn, MD, Vice President and Chief Scientific Officer at ARI. "We're using the hair cells from hair follicles and researching methods to promote their growth in controlled laboratory environments. If successful, we'll then be able to recombine the cells and restore them to the scalp, where they would ultimately elicit hair growth."

A dynamic field on the cutting-edge of the hair restoration industry, cell treatment represents a major advance on traditional hair transplant procedures, promising to overcome a key limitation of conventional transplantation: a finite hair supply for any one person. Through leading edge cell engineering, Aderans Research is pioneering efforts to multiply existing hair cells capable of eliciting hair growth, providing patients with a comprehensive solution to hair loss regardless of the quantity of their existing hair.

About the BIO International Convention:
The BIO International Convention is the largest global event for the biotechnology industry, offering key networking and partnering opportunities, and providing insight on major trends affecting the industry. The convention is produced by BIO, the world's largest biotechnology organization, representing more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and abroad. BIO works to create a favorable policy environment for biotechnological innovation. Its members are involved in marketing, research and development across the healthcare, agriculture, industrial and environmental biotechnology fields.

Learn more at: http://convention.bio.org/

About Aderans Research:
Aderans Research is dedicated to solving the pervasive problem of hair loss and becoming the world leader in the research and development of safe, effective cell engineered products for hair regeneration.

With offices in Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of Aderans Company, Ltd, the world's largest wig manufacturer, and an affiliate of Bosley, a global leader in medical hair restoration.

More information on ARI's study outcomes will be released as studies conclude. To see ARI's latest clinical updates, please visit http://aderansresearch.com/ari_clinicalupdates.html

Additional information on ARI can be found at www.aderansresearch.com.

Contact:
Vern Liebmann
Tel: 678.213.1913

###

Read the full story at http://www.prweb.com/releases/hair/regeneration/prweb2478234.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Aderans Research Launches Second Phase of Hair Loss Study
2. Pitt melanoma researchers present novel findings at ASCO
3. Indiana U. research at the American College of Sports Medicine conference
4. UTSA Dean George Perry co-edits textbook chronicling four decades of Alzheimers research
5. Researchers develop light-treatment device to improve sleep quality in the elderly
6. Cancer research partnership between UCSF, MMRF to drive drug development
7. AGA Institute presents cutting-edge research during DDW
8. MU researchers offer insights for advancing health communication through digital media
9. Raymond Tye Named Trustee at Schepens Eye Research Institute
10. 5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment
11. LSUHSC dental researcher funded to develop better dental materials
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aderans Research BIO International Press Release
(Date:8/22/2017)... ... August 22, 2017 , ... John Stewart joins Privis ... Member for t4 Leadership Development & Consulting. He has spent his career focusing ... physician leadership development, servant leadership, data driven process improvement, and supportive technology. These ...
(Date:8/21/2017)... (PRWEB) , ... August 22, 2017 , ... ... but not without risk to health and safety. By learning and implementing best ... eliminated. , In this webinar, attendees will gain a better understanding of ...
(Date:8/21/2017)... ... ... Five chefs from local senior assisted living homes will serve Mediterranean-inspired gourmet ... be able to vote for their favorite Chef among the following: , GREECE, Chef ... Cheese Sauce & Garlic Pita Crisp, Greek Mountain Ice Tea , ITALY, Chef Gabriel ...
(Date:8/21/2017)... ... , ... The American Hospital Association (AHA) has elected Claire Zangerle, Chief Nurse ... Board of Trustees for a three-year term beginning January 1, 2018. , The ... that are committed to the improvement of health in their communities. Founded in 1898, ...
(Date:8/20/2017)... ... August 20, 2017 , ... HIPAA Solutions, LC ... has assisted multiple clients in successfully passing audits such as Office of Civil ... (AICPA SOC Level 2), and State Data Use Agreement Audits. , HIPAA ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
(Date:8/7/2017)... , Aug. 7, 2017  Endo International plc ... reached agreements to resolve virtually all known U.S. mesh ... discussions to resolve the known remaining U.S. claims at ... payments beginning in the fourth quarter of 2017 and ... of its second quarter 2017 results, the Company intends ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
Breaking Medicine Technology: